0001752724-23-090866.txt : 20230428 0001752724-23-090866.hdr.sgml : 20230428 20230428104401 ACCESSION NUMBER: 0001752724-23-090866 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230428 DATE AS OF CHANGE: 20230428 PERIOD START: 20231130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Natixis Funds Trust II CENTRAL INDEX KEY: 0000052136 IRS NUMBER: 041990692 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-00242 FILM NUMBER: 23861504 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 800-283-1155 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: IXIS Advisor Funds Trust II DATE OF NAME CHANGE: 20050502 FORMER COMPANY: FORMER CONFORMED NAME: CDC NVEST FUNDS TRUST II DATE OF NAME CHANGE: 20010503 FORMER COMPANY: FORMER CONFORMED NAME: NVEST FUNDS TRUST II DATE OF NAME CHANGE: 20000202 0000052136 S000053353 Loomis Sayles Global Growth Fund C000167848 Class A LSAGX C000167849 Class C LSCGX C000167850 Class Y LSGGX C000188122 Class N LSNGX NPORT-P 1 primary_doc.xml NPORT-P false 0000052136 XXXXXXXX S000053353 C000167848 C000167849 C000167850 C000188122 Natixis Funds Trust II 811-00242 0000052136 R4B5ZXLI2IMIOWT67V76 888 BOYLSTON STREET Suite 800 BOSTON 02199-8197 617-449-2139 Loomis Sayles Global Growth Fund S000053353 5493008W63EBOWG4HO71 2023-11-30 2023-02-28 N 93636083.23 296414.29 93339668.94 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Salesforce Inc RCGZFPDMRW58VJ54VR07 Salesforce Inc 79466L302 11085.00000000 NS USD 1813616.85000000 1.943029014990 Long EC CORP US N 1 N N N Alnylam Pharmaceuticals Inc 529900S3ZI14OWRJII50 Alnylam Pharmaceuticals Inc 02043Q107 13524.00000000 NS USD 2589169.80000000 2.773922202000 Long EC CORP US N 1 N N N Expeditors International of Washington Inc 984500B055A804AB6E40 Expeditors International of Washington Inc 302130109 6954.00000000 NS USD 727110.24000000 0.778993806446 Long EC CORP US N 1 N N N Vertex Pharmaceuticals Inc 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals Inc 92532F100 5746.00000000 NS USD 1668006.34000000 1.787028343835 Long EC CORP US N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 000000000 15979.00000000 NS 2257117.77000000 2.418176318421 Long EC CORP DK N 2 N N N Under Armour Inc 549300D4549QKWETZ406 Under Armour Inc 904311107 83400.00000000 NS USD 828162.00000000 0.887256200289 Long EC CORP US N 1 N N N Reckitt Benckiser Group PLC 5493003JFSMOJG48V108 Reckitt Benckiser Group PLC 000000000 6720.00000000 NS 466267.18000000 0.499538069177 Long EC CORP GB N 2 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet Inc 02079K305 44237.00000000 NS USD 3983984.22000000 4.268264785212 Long EC CORP US N 1 N N N Visa Inc 549300JZ4OKEHW3DPJ59 Visa Inc 92826C839 17597.00000000 NS USD 3870284.18000000 4.146451582646 Long EC CORP US N 1 N N N Sodexo SA 969500LCBOG12HXPYM84 Sodexo SA 000000000 8897.00000000 NS 824019.69000000 0.882818312254 Long EC CORP FR N 2 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 000000000 5806.00000000 NS 1674095.44000000 1.793551936718 Long EC CORP CH N 2 N N N Alibaba Group Holding Ltd 5493001NTNQJDH60PM02 Alibaba Group Holding Ltd 01609W102 15083.00000000 NS USD 1324136.57000000 1.418621455419 Long EC CORP KY N 1 N N N NXP Semiconductors NV 724500M9BY5293JDF951 NXP Semiconductors NV 000000000 9881.00000000 NS USD 1763560.88000000 1.889401258894 Long EC CORP NL N 1 N N N Block Inc 549300OHIIUWSTIZME52 Block Inc 852234103 15210.00000000 NS USD 1167063.30000000 1.250340089324 Long EC CORP US N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 Microsoft Corp 594918104 13113.00000000 NS USD 3270644.46000000 3.504024063019 Long EC CORP US N 1 N N N Adyen NV 724500973ODKK3IFQ447 Adyen NV 000000000 2091.00000000 NS 2963844.74000000 3.175332389388 Long EC CORP NL N 2 N N N CRISPR Therapeutics AG 506700O6IRRIQLT3W370 CRISPR Therapeutics AG 000000000 33903.00000000 NS USD 1672095.96000000 1.791409782131 Long EC CORP CH N 1 N N N Doximity Inc N/A Doximity Inc 26622P107 41535.00000000 NS USD 1396822.05000000 1.496493469349 Long EC CORP US N 1 N N N Nestle SA KY37LUS27QQX7BB93L28 Nestle SA 000000000 10699.00000000 NS 1205462.98000000 1.291479810984 Long EC CORP CH N 2 N N N Netflix Inc 549300Y7VHGU0I7CE873 Netflix Inc 64110L106 8774.00000000 NS USD 2826368.62000000 3.028046544515 Long EC CORP US N 1 N N N Unilever PLC 549300MKFYEKVRWML317 Unilever PLC 000000000 16547.00000000 NS 825539.30000000 0.884446355311 Long EC CORP GB N 2 N N N FANUC Corp 529900QTSW745LOKW705 FANUC Corp 000000000 15000.00000000 NS 2549562.78000000 2.731488989573 Long EC CORP JP N 2 N N N Tesla Inc 54930043XZGB27CTOV49 Tesla Inc 88160R101 16883.00000000 NS USD 3473001.93000000 3.720820921523 Long EC CORP US N 1 N N N Yum China Holdings Inc 529900DO9BYZ7VA3K502 Yum China Holdings Inc 98850P109 29784.00000000 NS USD 1749214.32000000 1.874030987965 Long EC CORP US N 1 N N N Budweiser Brewing Co APAC Ltd 549300YF1MR4GTF18132 Budweiser Brewing Co APAC Ltd 000000000 168532.00000000 NS 505360.34000000 0.541420754689 Long EC CORP KY N 2 N N N Ambev SA 549300TH5Q6VRP8OT012 Ambev SA 02319V103 944116.00000000 NS USD 2407495.80000000 2.579284699999 Long EC CORP BR N 1 N N N Trip.com Group Ltd 2549004RMYDSRQL4KW41 Trip.com Group Ltd 89677Q107 61485.00000000 NS USD 2185791.75000000 2.341760769909 Long EC CORP KY N 1 N N N Deere & Co PWFTNG3EI0Y73OXWDH08 Deere & Co 244199105 2066.00000000 NS USD 866149.84000000 0.927954694757 Long EC CORP US N 1 N N N Meta Platforms Inc BQ4BKCS1HXDV9HN80Z93 Meta Platforms Inc 30303M102 26999.00000000 NS USD 4723205.06000000 5.060233353769 Long EC CORP US N 1 N N N Oracle Corp 1Z4GXXU7ZHVWFCD8TV52 Oracle Corp 68389X105 38962.00000000 NS USD 3405278.80000000 3.648265350275 Long EC CORP US N 1 N N N Experian PLC 635400RXXHHYT1JTSZ26 Experian PLC 000000000 68806.00000000 NS 2319734.06000000 2.485260646779 Long EC CORP JE N 2 N N N Boeing Co/The RVHJWBXLJ1RFUBSY1F30 Boeing Co/The 097023105 21733.00000000 NS USD 4380286.15000000 4.692845174773 Long EC CORP US N 1 N N N Autodesk Inc FRKKVKAIQEF3FCSTPG55 Autodesk Inc 052769106 4798.00000000 NS USD 953314.62000000 1.021339191392 Long EC CORP US N 1 N N N Baidu Inc 254900AL64IANZYI1E02 Baidu Inc 056752108 14630.00000000 NS USD 2014404.70000000 2.158144251930 Long EC CORP KY N 1 N N N Yum! Brands Inc 549300JE8XHZZ7OHN517 Yum! Brands Inc 988498101 5865.00000000 NS USD 745793.40000000 0.799010119137 Long EC CORP US N 1 N N N Fixed Income Clearing Corp 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 731396.68000000 PA USD 731396.68000000 0.783586108999 Long RA CORP US N 2 Repurchase N 1.95000000 2023-03-01 812200.00000000 USD 746084.63000000 USD UST N N N QUALCOMM Inc H1J8DDZKZP6H7RWC0H53 QUALCOMM Inc 747525103 11840.00000000 NS USD 1462595.20000000 1.566959918124 Long EC CORP US N 1 N N N Shopify Inc 549300HGQ43STJLLP808 Shopify Inc 82509L107 54652.00000000 NS USD 2248383.28000000 2.408818571496 Long EC CORP CA N 1 N N N MercadoLibre Inc 549300DKPDN9M5S8GB14 MercadoLibre Inc 58733R102 4641.00000000 NS USD 5662020.00000000 6.066038228226 Long EC CORP US N 1 N N N Novartis AG 5493007HIVTX6SY6XD66 Novartis AG 000000000 39116.00000000 NS 3292007.08000000 3.526911030846 Long EC CORP CH N 2 N N N Tencent Holdings Ltd 254900N4SLUMW4XUYY11 Tencent Holdings Ltd 000000000 68600.00000000 NS 3013487.80000000 3.228517771942 Long EC CORP KY N 2 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 Amazon.com Inc 023135106 46751.00000000 NS USD 4405346.73000000 4.719693973664 Long EC CORP US N 1 N N N Meituan 21380033K525E5JLIA77 Meituan 000000000 6420.00000000 NS 111418.62000000 0.119368989911 Long EC CORP KY N 2 N N N SEI Investments Co 5LJTIFADGZ6XH1RVOC11 SEI Investments Co 784117103 14816.00000000 NS USD 892664.00000000 0.956360795080 Long EC CORP US N 1 N N N 2023-03-30 Natixis Funds Trust II John Sgroi John Sgroi Assistant Treasurer XXXX NPORT-EX 2 NPORT_IAL7_12897325_0223.htm HTML

PORTFOLIO OF INVESTMENTS – as of February 28, 2023 (Unaudited)

Loomis Sayles Global Growth Fund

 

         Shares              

Description

             Value (†)            
               
 

Common Stocks – 98.9% of Net Assets

  
   Brazil – 8.6%

 

  944,116     

Ambev SA, ADR

   $ 2,407,496  
  4,641     

MercadoLibre, Inc.(a)

     5,662,020  
     

 

 

 
     8,069,516  
     

 

 

 
   Canada – 2.4%

 

  54,652     

Shopify, Inc., Class A(a)

     2,248,383  
     

 

 

 
   China – 13.5%

 

  15,083     

Alibaba Group Holding Ltd., ADR(a)(b)

     1,324,136  
  14,630     

Baidu, Inc., ADR(a)(b)

     2,014,405  
  168,532     

Budweiser Brewing Co. APAC Ltd., 144A

     505,360  
  6,420     

Meituan, Class B, 144A(a)

     111,419  
  9,881     

NXP Semiconductors NV

     1,763,561  
  68,600     

Tencent Holdings Ltd.(b)

     3,013,488  
  61,485     

Trip.com Group Ltd., ADR(a)(b)

     2,185,792  
  29,784     

Yum China Holdings, Inc.

     1,749,214  
     

 

 

 
     12,667,375  
     

 

 

 
   Denmark – 2.4%

 

  15,979     

Novo Nordisk AS, Class B

     2,257,118  
     

 

 

 
   France – 0.9%

 

  8,897     

Sodexo SA

     824,020  
     

 

 

 
   Japan – 2.7%

 

  15,000     

FANUC Corp.

     2,549,563  
     

 

 

 
   Netherlands – 3.2%

 

  2,091     

Adyen NV, 144A(a)

     2,963,845  
     

 

 

 
   Switzerland – 5.3%

 

  33,903     

CRISPR Therapeutics AG(a)

     1,672,096  
  39,116     

Novartis AG, (Registered)

     3,292,007  
     

 

 

 
     4,964,103  
     

 

 

 
   United Kingdom – 3.9%

 

     68,806     

Experian PLC

     2,319,734  
  6,720     

Reckitt Benckiser Group PLC

     466,267  
  16,547     

Unilever PLC

     825,539  
     

 

 

 
     3,611,540  
     

 

 

 
   United States – 56.0%

 

  13,524     

Alnylam Pharmaceuticals, Inc.(a)

     2,589,170  
  44,237     

Alphabet, Inc., Class A(a)

     3,983,984  
  46,751     

Amazon.com, Inc.(a)

     4,405,347  
  4,798     

Autodesk, Inc.(a)

     953,315  
  15,210     

Block, Inc.(a)

     1,167,063  
  21,733     

Boeing Co.(a)

     4,380,286  
  2,066     

Deere & Co.

     866,150  
  41,535     

Doximity, Inc., Class A(a)

     1,396,822  


        Shares             

Description

             Value (†)            
               
 

Common Stocks – continued

  
   United States – continued

 

  6,954     

Expeditors International of Washington, Inc.

   $ 727,110  
  26,999     

Meta Platforms, Inc., Class A(a)

     4,723,205  
  13,113     

Microsoft Corp.

     3,270,645  
  10,699     

Nestle SA, (Registered)

     1,205,463  
  8,774     

Netflix, Inc.(a)

     2,826,369  
  38,962     

Oracle Corp.

     3,405,279  
  11,840     

QUALCOMM, Inc.

     1,462,595  
  5,806     

Roche Holding AG

     1,674,095  
  11,085     

Salesforce, Inc.(a)

     1,813,617  
  14,816     

SEI Investments Co.

     892,664  
  16,883     

Tesla, Inc.(a)

     3,473,002  
  83,400     

Under Armour, Inc., Class A(a)

     828,162  
  5,746     

Vertex Pharmaceuticals, Inc.(a)

     1,668,006  
  17,597     

Visa, Inc., Class A

     3,870,284  
  5,865     

Yum! Brands, Inc.

     745,793  
     

 

 

 
        52,328,426  
     

 

 

 
  

Total Common Stocks
(Identified Cost $98,158,610)

     92,483,889  
     

 

 

 

Principal

        Amount         

             
 

Short-Term Investments – 0.8%

  
$     731,397     

Tri-Party Repurchase Agreement with Fixed Income Clearing Corporation, dated 2/28/2023 at 1.950% to be repurchased at $731,436 on 3/01/2023 collateralized by $812,200 U.S. Treasury Note, 0.500% due 3/31/2025 valued at $746,085 including accrued interest(c)
(Identified Cost $731,397)

     731,397  
     

 

 

 
  

Total Investments – 99.7%
(Identified Cost $98,890,007)

     93,215,286  
  

Other assets less liabilities – 0.3%

     293,124  
     

 

 

 
  

Net Assets – 100.0%

   $ 93,508,410  
     

 

 

 

 

(†)

Registered investment companies are required to value portfolio investments using an unadjusted, readily available market quotation. The Fund obtains readily available market quotations from independent pricing services. Fund investments for which readily available market quotations are not available are priced at fair value pursuant to the Fund’s Valuation Procedures. The Board of Trustees has approved a valuation designee who is subject to the Board’s oversight.


Unadjusted readily available market quotations that are utilized for exchange traded equity securities (including shares of closed-end investment companies and exchange-traded funds) include the last sale price quoted on the exchange where the security is traded most extensively. Shares of open-end investment companies are valued at net asset value per share.

Exchange traded equity securities for which there is no reported sale during the day are fair valued at the closing bid quotation as reported by an independent pricing service. Unlisted equity securities (except unlisted preferred equity securities) are fair valued at the last sale price quoted in the market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be fair valued using evaluated bids furnished by an independent pricing service, if available.

Debt securities and unlisted preferred equity securities are fair valued based on evaluated bids furnished to the Fund by an independent pricing service or bid prices obtained from broker-dealers. Broker-dealer bid prices may be used to fair value debt and unlisted equities where an independent pricing service is unable to price an investment or where an independent pricing service does not provide a reliable price for the investment.

The Fund may also fair value investments in other circumstances such as when extraordinary events occur after the close of a foreign market, but prior to the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of bankruptcy or a delisting of the issuer’s security from the primary market on which it has traded) as well as events affecting the securities markets in general (such as market disruptions or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing a Fund’s investments, the valuation designee may, among other things, use modeling tools or other processes that may take into account factors such as issuer specific information, or other related market activity and/or information that occurred after the close of the foreign market but before the time the Fund’s net asset value (“NAV”) is calculated. Fair valuation by the Fund’s valuation designee may require subjective determinations about the value of the investment, and fair values used to determine a Fund’s NAV may differ from quoted or published prices, or from prices that are used by others, for the same investments. In addition, the use of fair value pricing may not always result in adjustments to the prices of investments held by a Fund.

The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and liabilities denominated in currencies other than U.S. dollars are translated into U.S. dollars based upon foreign exchange rates prevailing at the end of the period.

(a)

Non-income producing security.

(b)

Security invests in variable interest entities based in China.

(c)

The Fund may enter into repurchase agreements, under the terms of a Master Repurchase Agreement, under which the Fund acquires securities as collateral and agrees to resell the securities at an agreed upon time and at an agreed upon price. It is the Fund’s policy that the market value of the collateral for repurchase agreements be at least equal to 102% of the repurchase price, including interest. Certain repurchase agreements are tri-party arrangements whereby the collateral is held in a segregated account for the benefit of the Fund and on behalf of the counterparty. Repurchase agreements could involve certain risks in the event of default or insolvency of the counterparty, including possible delays or restrictions upon the Fund’s ability to dispose of the underlying securities. As of February 28, 2023, the Fund had an investment in a repurchase agreement for which the value of the related collateral exceeded the value of the repurchase agreement.

 

144A

All or a portion of these securities are exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At February 28, 2023, the value of Rule 144A holdings amounted to $3,580,624 or 3.8% of net assets.

ADR

An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of the foreign issuer described. The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.


Fair Value Measurements

In accordance with accounting standards related to fair value measurements and disclosures, the Fund has categorized the inputs utilized in determining the value of the Fund’s assets or liabilities. These inputs are summarized in the three broad levels listed below:

 

   

Level 1 – quoted prices in active markets for identical assets or liabilities;

 

   

Level 2 – prices determined using other significant inputs that are observable either directly, or indirectly through corroboration with observable market data (which could include quoted prices for similar assets or liabilities, interest rates, credit risk, etc.); and

 

   

Level 3 – prices determined using significant unobservable inputs when quoted prices or observable inputs are unavailable such as when there is little or no market activity for an asset or liability (unobservable inputs reflect the Fund’s own assumptions in determining the fair value of assets or liabilities and would be based on the best information available).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The Fund’s pricing policies have been approved by the Board of Trustees. Investments for which market quotations are readily available are categorized in Level 1. Other investments for which an independent pricing service is utilized are categorized in Level 2. Broker-dealer bid prices for which the Fund has knowledge of the inputs used by the broker-dealer are categorized in Level 2. All other investments, including broker-dealer bid prices for which the Fund does not have knowledge of the inputs used by the broker-dealer, as well as investments fair valued by the valuation designee, are categorized in Level 3. All Level 2 and 3 securities are defined as being fair valued.

Under certain conditions and based upon specific facts and circumstances, the Fund’s valuation designee may determine that a fair valuation should be made for portfolio investment(s). These valuation designee fair valuations will be based upon a significant amount of Level 3 inputs.


The following is a summary of the inputs used to value the Fund’s investments as of February 28, 2023, at value:

Asset Valuation Inputs

 

Description

   Level 1      Level 2      Level 3      Total  

Common Stocks

           

China

   $ 9,037,108      $ 3,630,267      $ —        $ 12,667,375  

Denmark

     —          2,257,118        —          2,257,118  

France

     —          824,020        —          824,020  

Japan

     —          2,549,563        —          2,549,563  

Netherlands

     —          2,963,845        —          2,963,845  

Switzerland

     1,672,096        3,292,007        —          4,964,103  

United Kingdom

     —          3,611,540        —          3,611,540  

United States

     49,448,868        2,879,558        —          52,328,426  

All Other Common Stocks*

     10,317,899        —          —          10,317,899  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Common Stocks

   $ 70,475,971      $ 22,007,918      $ —        $ 92,483,889  
  

 

 

    

 

 

    

 

 

    

 

 

 

Short-Term Investments

     —          731,397        —          731,397  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 70,475,971      $ 22,739,315      $ —        $ 93,215,286  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Details of the major categories of the Fund’s investments are reflected within the Portfolio of Investments.


Industry Summary at February 28, 2023 (Unaudited)

 

Interactive Media & Services

     14.8

Internet & Direct Marketing Retail

     12.2  

IT Services

     10.9  

Software

     10.0  

Pharmaceuticals

     7.7  

Biotechnology

     6.4  

Hotels, Restaurants & Leisure

     5.9  

Aerospace & Defense

     4.7  

Automobiles

     3.7  

Machinery

     3.6  

Semiconductors & Semiconductor Equipment

     3.5  

Beverages

     3.1  

Entertainment

     3.0  

Professional Services

     2.5  

Other Investments, less than 2% each

     6.9  

Short-Term Investments

     0.8  
  

 

 

 

Total Investments

     99.7  

Other assets less liabilities

     0.3  
  

 

 

 

Net Assets

     100.0
  

 

 

 


Currency Exposure Summary at February 28, 2023 (Unaudited)

 

United States Dollar

     76.2

Swiss Franc

     6.6  

Euro

     5.0  

Hong Kong Dollar

     3.8  

British Pound

     3.0  

Japanese Yen

     2.7  

Danish Krone

     2.4  
  

 

 

 

Total Investments

     99.7  

Other assets less liabilities

     0.3  
  

 

 

 

Net Assets

     100.0